Psychostimulants: New concepts for palliative care from the modafinil experience? [1]

Journal of Pain and Symptom Management

Volumn 28, Issue 2, 2004, Pages 97-99

  Caraceni, Augusto ^a   Simonetti, Fabio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHETAMINE; ANTIHISTAMINIC AGENT; CEFTRIAXONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MODAFINIL; OPIATE; OREXIN; SEROTONIN AGONIST;

4 AMINOBUTYRIC ACID RELEASE; ADULT; AGED; ANAMNESIS; ANEMIA; ANTICHOLINERGIC EFFECT; BILIARY TRACT DRAINAGE; BLOOD PRESSURE; BLOOD TRANSFUSION; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN STEM; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS; DELIRIUM; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAM; HEART RATE; HIPPOCAMPUS; HUMAN; HYPOACUSIS; HYPOTHALAMUS; INSOMNIA; KIDNEY CARCINOMA; LETTER; LIVER FUNCTION; MALE; MYELODYSPLASIA; NERVE CELL; NEUROPHARMACOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPTIC NUCLEUS; REFRACTORY ANEMIA; SEPSIS; SLEEP WAKING CYCLE; SOMNOLENCE; STROKE; THALAMUS NUCLEUS; WAKEFULNESS;

AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; MALE; PALLIATIVE CARE; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 3242772208     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.04.006     Document Type: Letter

References (11)

1. Pace-Schott E.F., Hobson J.A. Basic mechanisms of sleep: new evidence on the neuroanatomy and neuromodulation of the NREM-REM cycle. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychophamacology. The fifth generation of progress. 2002;1859-1877 Lippincott Williams & Wilkins, Philadelphia
2. Silber M.H., Rye D.B. Solving the mystery of narcolepsy. The hypocretin story. Neurology. 56:2001;1616-1618
3. Overeem S., Dalmau J., Bataller L., et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology. 62:2004;138-140
4. Scammell T.E., Estabrooke I.V., McCarthy M.T., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci. 20:2000;8620-8628
5. Ishizuka T., Sakamoto Y., Sakurai T., et al. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett. 339:2003;143-146
6. Ault A. Narcolepsy drug could be approved for wider use. Lancet. 362:2003;1128
7. Kingshott R.N., Vennelle M., Coleman E.L., et al. Randomized double blind placebo-controlled crossover trial of modafinil in the treatement of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 163:2001;918-923
8. Pack A. Should a pharmaceutical be approved for the broad indication of excessive sleepiness? Am J Respir Crit Care Med. 167:2003;109-111
9. Vastag B. Poised to challenge need for sleep, "wakefulness enhancer" rouses concerns. JAMA. 291:(2):2004;167-170
10. Webster L., Andrews M., Stoddard G. Modafinil treatment of opiod-induced sedation. Pain Med. 4:2003;135-140
11. Pappagallo M. Modafinil: a gift to portmanteau. Am J Hosp Palliat Care. 18:2001;408-410